Stay updated on EPX-100 Add-on Control in Dravet Syndrome Clinical Trial
Sign up to get notified when there's something new on the EPX-100 Add-on Control in Dravet Syndrome Clinical Trial page.

Latest updates to the EPX-100 Add-on Control in Dravet Syndrome Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe record history now includes a new revision entry for v3.6.6 and removes the prior v3.6.5 entry, documenting the latest release applied to the study record.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedA new version entry (36) on 2026-08-11 adds the Contacts/Locations and Study Status sections to the study record history. This reflects updated contact details and the current status of the study within its history.SummaryDifference0.3%

- Check34 days agoChange DetectedThe study record history now includes a new revision entry (v3.6.5) as the latest version. The previous revision (v3.6.4) is removed from the current history view.SummaryDifference0.1%

- Check49 days agoChange DetectedRevision: v3.6.4 was added and Revision: v3.6.3 removed from the Record History, reflecting a small UI release update to the page rather than a change to study data.SummaryDifference0.1%

- Check70 days agoChange DetectedA new version entry on 2026-06-30 adds core study sections (Contacts/Locations, Eligibility, Arms and Interventions, Study Status) to the record, reflecting substantive updates to the trial record; the earlier revision entry (v3.6.2) from 2026-05-14 is removed.SummaryDifference0.5%

- Check78 days agoChange DetectedThe page history now shows a new frontend release (Revision: v3.6.2) added and the previous release (Revision: v3.6.0) removed, indicating a new build of the Record History page.SummaryDifference0.1%

Stay in the know with updates to EPX-100 Add-on Control in Dravet Syndrome Clinical Trial
Enter your email address, and we'll notify you when there's something new on the EPX-100 Add-on Control in Dravet Syndrome Clinical Trial page.